These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9086466)

  • 41. Joint effect of hypertension and APOE genotype on CSF biomarkers for Alzheimer's disease.
    Kester MI; van der Flier WM; Mandic G; Blankenstein MA; Scheltens P; Muller M
    J Alzheimers Dis; 2010; 20(4):1083-90. PubMed ID: 20413898
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
    J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stability of CSF beta-amyloid(1-42) and tau levels by APOE genotype in Alzheimer patients.
    Huey ED; Mirza N; Putnam KT; Soares H; Csako G; Levy JA; Copenhaver B; Cohen RM; Sunderland T
    Dement Geriatr Cogn Disord; 2006; 22(1):48-53. PubMed ID: 16682793
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum amyloid A (SAA)-induced remodeling of CSF-HDL.
    Miida T; Yamada T; Seino U; Ito M; Fueki Y; Takahashi A; Kosuge K; Soda S; Hanyu O; Obayashi K; Miyazaki O; Okada M
    Biochim Biophys Acta; 2006 Apr; 1761(4):424-33. PubMed ID: 16651021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Soluble LR11 competes with amyloid β in binding to cerebrospinal fluid-high-density lipoprotein.
    Yano K; Hirayama S; Misawa N; Furuta A; Ueno T; Motoi Y; Seino U; Ebinuma H; Ikeuchi T; Schneider WJ; Bujo H; Miida T
    Clin Chim Acta; 2019 Feb; 489():29-34. PubMed ID: 30448281
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cerebrospinal fluid apo E and apo A-I concentrations in early- and late-onset Alzheimer's disease.
    Song H; Saito K; Seishima M; Noma A; Urakami K; Nakashima K
    Neurosci Lett; 1997 Aug; 231(3):175-8. PubMed ID: 9300650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel large apolipoprotein E-containing lipoproteins of density 1.006-1.060 g/ml in human cerebrospinal fluid.
    Guyton JR; Miller SE; Martin ME; Khan WA; Roses AD; Strittmatter WJ
    J Neurochem; 1998 Mar; 70(3):1235-40. PubMed ID: 9489746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease.
    Yassine HN; Rawat V; Mack WJ; Quinn JF; Yurko-Mauro K; Bailey-Hall E; Aisen PS; Chui HC; Schneider LS
    Alzheimers Res Ther; 2016 Jun; 8():25. PubMed ID: 27358067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased protein glycation in cerebrospinal fluid of Alzheimer's disease.
    Shuvaev VV; Laffont I; Serot JM; Fujii J; Taniguchi N; Siest G
    Neurobiol Aging; 2001; 22(3):397-402. PubMed ID: 11378244
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dependence of cerebrospinal fluid Tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease.
    Golombowski S; Müller-Spahn F; Romig H; Mendla K; Hock C
    Neurosci Lett; 1997 Apr; 225(3):213-5. PubMed ID: 9147408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease.
    Varges D; Jung K; Gawinecka J; Heinemann U; Schmitz M; von Ahsen N; Krasnianski A; Armstrong VW; Zerr I
    J Alzheimers Dis; 2011; 23(4):717-26. PubMed ID: 21157024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo.
    Darreh-Shori T; Forsberg A; Modiri N; Andreasen N; Blennow K; Kamil C; Ahmed H; Almkvist O; Långström B; Nordberg A
    Neurobiol Aging; 2011 Dec; 32(12):2320.e15-32. PubMed ID: 20538374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 54. APOE ε4 is associated with higher levels of CSF SNAP-25 in prodromal Alzheimer's disease.
    Wang S; Zhang J; Pan T;
    Neurosci Lett; 2018 Oct; 685():109-113. PubMed ID: 30144541
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype.
    Nitsch RM; Rebeck GW; Deng M; Richardson UI; Tennis M; Schenk DB; Vigo-Pelfrey C; Lieberburg I; Wurtman RJ; Hyman BT
    Ann Neurol; 1995 Apr; 37(4):512-8. PubMed ID: 7717688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations.
    Lautner R; Insel PS; Skillbäck T; Olsson B; Landén M; Frisoni GB; Herukka SK; Hampel H; Wallin A; Minthon L; Hansson O; Blennow K; Mattsson N; Zetterberg H
    Alzheimers Res Ther; 2017 Oct; 9(1):87. PubMed ID: 29061195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Haptoglobin interacts with apolipoprotein E and beta-amyloid and influences their crosstalk.
    Spagnuolo MS; Maresca B; La Marca V; Carrizzo A; Veronesi C; Cupidi C; Piccoli T; Maletta RG; Bruni AC; Abrescia P; Cigliano L
    ACS Chem Neurosci; 2014 Sep; 5(9):837-47. PubMed ID: 25058565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predominant apolipoprotein J exists as lipid-poor mixtures in cerebrospinal fluid.
    Suzuki T; Tozuka M; Kazuyoshi Y; Sugano M; Nakabayashi T; Okumura N; Hidaka H; Katsuyama T; Higuchi K
    Ann Clin Lab Sci; 2002; 32(4):369-76. PubMed ID: 12458888
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Temporal alterations in cerebrospinal fluid amyloid beta-protein and apolipoprotein E after subarachnoid hemorrhage.
    Kay A; Petzold A; Kerr M; Keir G; Thompson E; Nicoll J
    Stroke; 2003 Dec; 34(12):e240-3. PubMed ID: 14605321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.